BE assessment regarding first time point Cmax [Study As­sess­ment]

posted by Mann – India, 2018-12-10 00:28 (1260 d 22:06 ago) – Posting: # 19673
Views: 6,781

Dear Ohlbe,

Thank you for your detailed clarification.

Could you please share your views and suggestions from US-FDA and ICH perspective?

Best regards,
Mann

Complete thread:

UA Flag
Activity
 Admin contact
22,092 posts in 4,630 threads, 1,567 registered users;
online 10 (0 registered, 10 guests [including 4 identified bots]).
Forum time: Monday 23:35 CEST (Europe/Vienna)

There is no adequate defense, except stupidity,
against the impact of a new idea.    Percy Williams Bridgman

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5